tropicamide has been researched along with Cataract in 15 studies
Tropicamide: One of the MUSCARINIC ANTAGONISTS with pharmacologic action similar to ATROPINE and used mainly as an ophthalmic parasympatholytic or mydriatic.
Cataract: Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "02%), and lidocaine (1%) intracamerally was used for mydriasis and analgesia." | 9.51 | Evaluation of efficacy of intracameral lidocaine and tropicamide injection in manual small-incision cataract surgery: A prospective clinical study. ( Bhat, KT; Heda, AS; Undre, AA; Wadgaonkar, SP, 2022) |
| "31%/lidocaine 1% in pediatric cataract surgery, a combination widely used in adult patients but still off-label in children." | 8.31 | Efficacy and safety of intraoperative use of tropicamide 0.02%/phenylephrine0.31%/lidocaine1% intracameral combination during pediatric cataract surgery. ( Caputo, R; Dellavalle, A; Lembo, A; Nucci, P; Pichi, F; Schiavetti, I; Serafino, M, 2023) |
| "02%), and lidocaine (1%) intracamerally was used for mydriasis and analgesia." | 5.51 | Evaluation of efficacy of intracameral lidocaine and tropicamide injection in manual small-incision cataract surgery: A prospective clinical study. ( Bhat, KT; Heda, AS; Undre, AA; Wadgaonkar, SP, 2022) |
| "31% and lidocaine 1%) and mydriatic drops (tropicamide 1% and phenylephrine 10%) used for cataract surgery in terms of efficacy in pupil dilation and impact on corneal endothelial cell density (CD) and central corneal thickness (CCT)." | 5.34 | Mydrane intracameral injection site can be an alternative to mydriatic drops instillation in cataract surgery. ( Bolsega-Pacud, J; Kubicka-Trzaska, A; Markiewicz, A; Nazim-Lipski, G; Romanowska-Dixon, B, 2020) |
| "We evaluated, in a real-life setting, the effect of Mydrane® (ready-to-use combination of tropicamide, phenylephrine hydrochloride and lidocaine, injected into the anterior chamber at the beginning of cataract surgery to induce mydriasis and intraocular anaesthesia) on the pupil diameter during cataract surgery in patients with a preoperative pupil diameter <6 mm after the use of topical mydriatics." | 4.31 | Pupil diameter during cataract surgery after intracameral injection of the first ready-to-use combination of mydriatics and anaesthetic at the beginning of surgery in patients with a preoperative pupil diameter <6 mm. ( Grabska-Liberek, I; Jurowski, P; Kęcik, D; Kopacz, D; Mianowska, K; Mrukwa-Kominek, E; Omulecki, W; Romaniuk, W; Romanowska-Dixon, B; Szaflik, J; Szaflik, JP, 2023) |
| "31%/lidocaine 1% in pediatric cataract surgery, a combination widely used in adult patients but still off-label in children." | 4.31 | Efficacy and safety of intraoperative use of tropicamide 0.02%/phenylephrine0.31%/lidocaine1% intracameral combination during pediatric cataract surgery. ( Caputo, R; Dellavalle, A; Lembo, A; Nucci, P; Pichi, F; Schiavetti, I; Serafino, M, 2023) |
| " Pupils were dilated with phenylephrine alone for cataract identification because there were concerns that patient discomfort, due to cycloplegia occurring with the usual dilating agents of tropicamide and phenylephrine, may influence future compliance in an associated intervention study." | 3.70 | Comparative pupil dilation using phenylephrine alone or in combination with tropicamide. ( Battistutta, D; Eyeson-Annan, ML; Green, A; Hirst, LW, 1998) |
| "5% tropicamide and of 10% phenylephrine hydrochloride instilled after routine applanation tonometry gave consistent pupil dilatation in a population with cataract studied over 5 years." | 3.68 | Reproducibility of mydriasis. ( Maclean, H, 1992) |
| "Tropicamide was rapidly absorbed systemically with the mean peak concentration in plasma being 2." | 1.29 | Systemic absorption and anticholinergic activity of topically applied tropicamide. ( Iisalo, E; Kaila, T; Saari, KM; Vuori, ML, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 4 (26.67) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 5 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kęcik, D | 1 |
| Grabska-Liberek, I | 1 |
| Jurowski, P | 1 |
| Mrukwa-Kominek, E | 1 |
| Omulecki, W | 1 |
| Romanowska-Dixon, B | 2 |
| Szaflik, JP | 1 |
| Romaniuk, W | 1 |
| Szaflik, J | 1 |
| Kopacz, D | 1 |
| Mianowska, K | 1 |
| Nucci, P | 1 |
| Lembo, A | 1 |
| Caputo, R | 1 |
| Dellavalle, A | 1 |
| Serafino, M | 1 |
| Schiavetti, I | 1 |
| Pichi, F | 1 |
| Bhat, KT | 1 |
| Wadgaonkar, SP | 1 |
| Undre, AA | 1 |
| Heda, AS | 1 |
| Deeks, ED | 1 |
| Nazim-Lipski, G | 1 |
| Bolsega-Pacud, J | 1 |
| Kubicka-Trzaska, A | 1 |
| Markiewicz, A | 1 |
| Chen, X | 1 |
| Yan, H | 1 |
| Chen, Y | 1 |
| Li, G | 1 |
| Bin, Y | 1 |
| Zhou, X | 1 |
| Arimura, S | 1 |
| Takamura, Y | 1 |
| Takihara, Y | 1 |
| Matsumura, T | 1 |
| Tomomatsu, T | 1 |
| Inatani, M | 1 |
| Shafiq, A | 1 |
| Arriola-Villalobos, P | 1 |
| Almendral-Gómez, J | 1 |
| Garzón, N | 1 |
| Ruiz-Medrano, J | 1 |
| Fernández-Pérez, C | 1 |
| Martínez-de-la-Casa, JM | 1 |
| Díaz-Valle, D | 1 |
| Wiggins, MN | 1 |
| Irak-Dersu, I | 1 |
| Turner, SD | 1 |
| Thostenson, JD | 1 |
| Vuori, ML | 1 |
| Kaila, T | 1 |
| Iisalo, E | 1 |
| Saari, KM | 1 |
| Eyeson-Annan, ML | 1 |
| Hirst, LW | 1 |
| Battistutta, D | 1 |
| Green, A | 1 |
| Hoh, ST | 1 |
| Greenfield, DS | 1 |
| Liebmann, JM | 1 |
| Hillenkamp, J | 1 |
| Ishikawa, H | 1 |
| Mistlberger, A | 1 |
| Lim, AS | 1 |
| Ritch, R | 1 |
| Maclean, H | 1 |
| Bosse, JC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of Light Sensitivity and Visual Acuity Changes as Consequence of Rigid Gas Permeable (RGP) Scleral Contact Lenses With a Passive Artificial Iris[NCT04040790] | 10 participants (Actual) | Interventional | 2019-09-16 | Terminated (stopped due to Several reasons: Financing ended before all study assessments were performed, covid-19 delayed design, production and shipment of IMD, experience gained during the study made it clear that lens design should be changed) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 trials available for tropicamide and Cataract
| Article | Year |
|---|---|
Evaluation of efficacy of intracameral lidocaine and tropicamide injection in manual small-incision cataract surgery: A prospective clinical study.
Topics: Cataract; Humans; Lidocaine; Mydriasis; Mydriatics; Phacoemulsification; Phenylephrine; Prospective | 2022 |
Tropicamide/Phenylephrine/Lidocaine Intracameral Injection: A Review in Cataract Surgery.
Topics: Adult; Aged; Aged, 80 and over; Cataract; Cataract Extraction; Drug Combinations; Drug Therapy, Comb | 2019 |
Mydrane intracameral injection site can be an alternative to mydriatic drops instillation in cataract surgery.
Topics: Aged; Aged, 80 and over; Cataract; Cataract Extraction; Female; Humans; Injections, Intraocular; Lid | 2020 |
Effect of pharmacological pupil dilation on measurements and iol power calculation made using the new swept-source optical coherence tomography-based optical biometer.
Topics: Aged; Aged, 80 and over; Axial Length, Eye; Biometry; Cataract; Dilatation; Female; Humans; Lens, Cr | 2016 |
11 other studies available for tropicamide and Cataract
| Article | Year |
|---|---|
Pupil diameter during cataract surgery after intracameral injection of the first ready-to-use combination of mydriatics and anaesthetic at the beginning of surgery in patients with a preoperative pupil diameter <6 mm.
Topics: Anesthetics; Cataract; Humans; Lidocaine; Mydriasis; Mydriatics; Ophthalmic Solutions; Phacoemulsifi | 2023 |
Efficacy and safety of intraoperative use of tropicamide 0.02%/phenylephrine0.31%/lidocaine1% intracameral combination during pediatric cataract surgery.
Topics: Adult; Cataract; Child; Humans; Lidocaine; Mydriasis; Mydriatics; Ophthalmology; Phacoemulsification | 2023 |
Moderate oxidative stress promotes epithelial-mesenchymal transition in the lens epithelial cells via the TGF-β/Smad and Wnt/β-catenin pathways.
Topics: Animals; Antioxidants; beta Catenin; Capsule Opacification; Cataract; Cell Proliferation; Cell Survi | 2021 |
Determinants of anterior chamber angle narrowing after mydriasis in the patients with cataract.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anterior Chamber; Cataract; Female; Glaucoma, Angle-C | 2015 |
Seeing red in young children: the importance of the red reflex.
Topics: Cataract; Diagnosis, Differential; Humans; Infant; Mydriatics; Ophthalmoscopy; Reflex, Pupillary; Re | 2015 |
Glare testing in patients with cataract after dilation.
Topics: Aged; Aged, 80 and over; Cataract; Drug Combinations; Female; Glare; Humans; Male; Middle Aged; Mydr | 2009 |
Systemic absorption and anticholinergic activity of topically applied tropicamide.
Topics: Absorption; Administration, Topical; Aged; Animals; Brain; Cataract; Choline; Female; Glaucoma, Open | 1994 |
Comparative pupil dilation using phenylephrine alone or in combination with tropicamide.
Topics: Accommodation, Ocular; Adult; Aged; Cataract; Drug Combinations; Female; Humans; Male; Middle Aged; | 1998 |
Effect of pupillary dilation on retinal nerve fiber layer thickness as measured by scanning laser polarimetry in eyes with and without cataract.
Topics: Adult; Aged; Cataract; Diagnostic Techniques, Ophthalmological; Humans; Lasers; Middle Aged; Mydriat | 1999 |
Reproducibility of mydriasis.
Topics: Cataract; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Phenylephrine; Photography | 1992 |
Potential visual acuity measured with and without pupil dilation.
Topics: Aged; Cataract; Humans; Interferometry; Iris; Middle Aged; Phenylephrine; Pupil; Tropicamide; Visual | 1989 |